Lomecel-B
Phase 2- Indications
- Aging Frailty, Alzheimer's disease, Metabolic Syndrome, Acute Respiratory Distress Syndrome, Hypoplastic Left Heart Syndrome
Company intelligence / Profile preview
Armistice Capital
New York, New York, USAarmisticecapital.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Global hedge fund focused on value/event-driven investing primarily in healthcare/life sciences. No internal drug development programs but major investor across many public biotechs/pharmas.[1][2]
- Industry
- Investors
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Armistice Capital.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Armistice Capital.